Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Organon NV

Division of Merck & Co. Inc.
www.organon.com

Latest From Guangdong Techpool Bio-Pharma Co. Ltd.

China Options For Takeda As It Pursues Emerging Markets Buy

Takeda’s recent revelation that it had set aside around $450m for a planned M&A transaction in an undisclosed emerging market has triggered speculation about where and how the company might spend its money. Might China be in the mix?

Commercial China

Takeda’s Planned Emerging Markets Deal: India Yay Or Nay?

Takeda tantalizingly disclosed during its third quarter results that it has set aside funds for an acquisition worth around $450m in an undisclosed emerging market. What are the likely targets?

Emerging Markets Deals

Commercial Model Innovation Key To Lowering China Compliance Risks

Balanced scorecards, big data, and platform strategies are among the new tools being employed by pharma companies ramping up compliance and lowering risks in China, where market access remains challenging and pricing pressures persistent. Such commercial model innovation should also improve physician interaction while providing new medical solutions, said executives at a recent RDPAC gathering in Beijing.

BioPharmaceutical China

Takeda China R&D Head Benny Li On Engaging CFDA For Global Trials: An Interview With PharmAsia News

Takeda opened its Shanghai Development Center in 2012 to accelerate introducing new medicines to China. Center Head Benny Li discusses Takeda’s R&D strategy and shares his experience about working with China FDA.

BioPharmaceutical China
See All

Company Information

Advertisement
Advertisement
UsernamePublicRestriction

Register